Panacea Life Sciences Holdings, Inc. Stockholders' Equity Attributable to Noncontrolling Interest
Panacea Life Sciences Holdings, Inc. (PLSH) had Stockholders' Equity Attributable to Noncontrolling Interest of -$2.02 million as of 2021-03-31, per its 10-Q/A filed 2021-05-27.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2021-05-27
- 2021-03-31: Stockholders' Equity Attributable to Noncontrolling Interest -$2.02M.
- 2020-12-31: Stockholders' Equity Attributable to Noncontrolling Interest -$2.02M.
- 2020-09-30: Stockholders' Equity Attributable to Noncontrolling Interest -$2.02M.
- 2020-06-30: Stockholders' Equity Attributable to Noncontrolling Interest -$847.91K.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2021-03-31 | -$2.02M 10-Q/A · filed 2021-05-27 |
| 2020-12-31 | -$2.02M 10-Q/A · filed 2021-05-27 |
| 2020-09-30 | -$2.02M 10-Q · filed 2020-11-18 |
| 2020-06-30 | -$847.91K 10-Q · filed 2020-08-19 |
| 2020-03-31 | -$693.29K 10-Q · filed 2020-06-29 |
| 2019-12-31 | -$537.47K 10-K/A · filed 2021-04-23 |
| 2019-09-30 | -$361.63K 10-Q · filed 2019-11-14 |
| 2019-06-30 | -$187.95K 10-Q · filed 2019-08-14 |
| 2019-03-31 | -$35.60K 10-Q · filed 2019-05-20 |
| 2018-12-31 | $0.00 10-K · filed 2020-05-22 |